Evidence map›Paper›PMID 25961932›Full record

ArticleOncogene2016

H3K9me3 facilitates hypoxia-induced p53-dependent apoptosis through repression of APAK.

M M Olcina, K B Leszczynska, J M Senra, N F Isa, H Harada, E M Hammond

Open access · hybridAbstract read
In one paragraph

Article in Oncogene, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 1 synthesis or guideline pooled it, 78 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Astrocyte KDM4A mediates chemokines and drives neutrophil infiltration to aggravate cerebral ischemia and reperfusion injury.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

M M OlcinaDepartment of Oncology, CR-UK & MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.
K B LeszczynskaDepartment of Oncology, CR-UK & MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.
J M SenraDepartment of Oncology, CR-UK & MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.
N F IsaDepartment of Oncology, CR-UK & MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.
H HaradaDepartment of Radiation Oncology and Image-Applied Therapy, Kyoto University Graduate School of Medicine, Kyoto, Japan.
E M HammondDepartment of Oncology, CR-UK & MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.
University of Oxford · GBCRUK/MRC Oxford Institute for Radiation Oncology · GBKyoto University · JP

Funding

Cancer Research UK 19276Medical Research Council
6 · The paper itself

Abstract

Regions of hypoxia occur in most solid tumors, and they are associated with a poor prognostic outcome. Despite the absence of detectable DNA damage, severe hypoxia (<0.1% O2) induces a DNA damage response, including the activation of p53 and subsequent induction of p53-dependent apoptosis. Factors affecting hypoxia-induced p53-dependent apoptosis are unclear. Here we asked whether H3K9me3, through mediating gene repression, could regulate hypoxia-induced p53-dependent apoptosis. Under hypoxic conditions, increases in H3K9me3 occur in an oxygen-dependent but HIF-1-independent manner. We demonstrate that under hypoxic conditions, which induce p53 activity, the negative regulator of p53, APAK, is repressed by increases in H3K9me3 along the APAK loci. APAK repression in hypoxia is mediated by the methyltransferase SETDB1 but not Suv39h1 or G9a. Interestingly, increasing hypoxia-induced H3K9me3 through pharmacological inhibition of JMJD2 family members leads to an increase in apoptosis and decreased clonogenic survival and again correlates with APAK expression. The relevance of understanding the mechanisms of APAK expression regulation to human disease was suggested by analysis of patients with colorectal cancer, which demonstrates that high APAK expression correlates with poor prognosis. Together, these data demonstrate the functional importance of H3K9me3 in hypoxia, and they provide a novel mechanistic link between H3K9me3, p53 and apoptosis in physiologically relevant conditions of hypoxia.

Indexed as

ApoptosisApoptosis Regulatory ProteinsCell HypoxiaDNA-Binding ProteinsGene Expression Regulation, NeoplasticGene Knockdown TechniquesHCT116 CellsHistone-Lysine N-MethyltransferaseHistonesHumansHypoxia-Inducible Factor 1, alpha SubunitOxygenTumor Cells, CulturedTumor Suppressor Protein p53Apoptosis Regulatory ProteinsDNA-Binding ProteinsHIF1A protein, humanHistone-Lysine N-MethyltransferaseHistonesHypoxia-Inducible Factor 1, alpha SubunitOxygenTP53 protein, humanTumor Suppressor Protein p53ZNF420 protein, human

Identifiers

PMID25961932
PMCPMC4753255
OpenAlexW1912093430

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.